Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 3
2015 2
2016 5
2017 4
2018 3
2019 4
2020 10
2021 9
2022 7
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

44 results

Results by year

Filters applied: . Clear all
Page 1
Immunohistochemistry for VM Markers.
Biagioni A, Andreucci E. Biagioni A, et al. Methods Mol Biol. 2022;2514:141-152. doi: 10.1007/978-1-0716-2403-6_14. Methods Mol Biol. 2022. PMID: 35771426
MAP Kinases Pathways in Gastric Cancer.
Magnelli L, Schiavone N, Staderini F, Biagioni A, Papucci L. Magnelli L, et al. Among authors: biagioni a. Int J Mol Sci. 2020 Apr 21;21(8):2893. doi: 10.3390/ijms21082893. Int J Mol Sci. 2020. PMID: 32326163 Free PMC article. Review.
The CAIX inhibitor SLC-0111 exerts anti-cancer activity on gastric cancer cell lines and resensitizes resistant cells to 5-Fluorouracil, taxane-derived, and platinum-based drugs.
Andreucci E, Biagioni A, Peri S, Versienti G, Cianchi F, Staderini F, Antonuzzo L, Supuran CT, Olivo E, Pasqualini E, Messerini L, Massi D, Lulli M, Ruzzolini J, Peppicelli S, Bianchini F, Schiavone N, Calorini L, Magnelli L, Papucci L. Andreucci E, et al. Among authors: biagioni a. Cancer Lett. 2023 Sep 1;571:216338. doi: 10.1016/j.canlet.2023.216338. Epub 2023 Aug 6. Cancer Lett. 2023. PMID: 37549770
Delivery systems of CRISPR/Cas9-based cancer gene therapy.
Biagioni A, Laurenzana A, Margheri F, Chillà A, Fibbi G, Del Rosso M. Biagioni A, et al. J Biol Eng. 2018 Dec 18;12:33. doi: 10.1186/s13036-018-0127-2. eCollection 2018. J Biol Eng. 2018. PMID: 30574185 Free PMC article. Review.
Update on gastric cancer treatments and gene therapies.
Biagioni A, Skalamera I, Peri S, Schiavone N, Cianchi F, Giommoni E, Magnelli L, Papucci L. Biagioni A, et al. Cancer Metastasis Rev. 2019 Sep;38(3):537-548. doi: 10.1007/s10555-019-09803-7. Cancer Metastasis Rev. 2019. PMID: 31486976 Review.
EMT signaling: potential contribution of CRISPR/Cas gene editing.
Mohammadinejad R, Biagioni A, Arunkumar G, Shapiro R, Chang KC, Sedeeq M, Taiyab A, Hashemabadi M, Pardakhty A, Mandegary A, Thiery JP, Aref AR, Azimi I. Mohammadinejad R, et al. Among authors: biagioni a. Cell Mol Life Sci. 2020 Jul;77(14):2701-2722. doi: 10.1007/s00018-020-03449-3. Epub 2020 Feb 1. Cell Mol Life Sci. 2020. PMID: 32008085 Review.
Endothelial Progenitor Cells as Shuttle of Anticancer Agents.
Laurenzana A, Margheri F, Chillà A, Biagioni A, Margheri G, Calorini L, Fibbi G, Del Rosso M. Laurenzana A, et al. Among authors: biagioni a. Hum Gene Ther. 2016 Oct;27(10):784-791. doi: 10.1089/hum.2016.066. Hum Gene Ther. 2016. PMID: 27502560 Review.
44 results